Suven Life Sciences Limited (BOM:530239)
India flag India · Delayed Price · Currency is INR
136.05
-2.05 (-1.48%)
At close: Mar 9, 2026

Suven Life Sciences Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2020 - 2016
Market Capitalization
35,87924,73021,74210,57013,4848,961
Upgrade
Market Cap Growth
32.52%13.74%105.69%-21.61%50.48%228.97%
Upgrade
Enterprise Value
33,30423,06719,87010,46813,3138,934
Upgrade
Last Close Price
136.05113.4099.7048.4785.4764.87
Upgrade
Forward PE
-3.653.653.653.653.65
Upgrade
PS Ratio
508.09371.55185.9477.75112.8363.67
Upgrade
PB Ratio
12.7622.488.052.8214.038.30
Upgrade
P/TBV Ratio
12.7622.528.062.8214.068.31
Upgrade
PEG Ratio
-0.130.130.130.130.13
Upgrade
EV/Sales Ratio
-346.57169.9377.00111.4063.48
Upgrade
Debt / Equity Ratio
--0.000.000.030.04
Upgrade
Net Debt / Equity Ratio
-0.91-0.55-0.89-0.60-0.49-0.38
Upgrade
Net Debt / EBITDA Ratio
0.930.361.861.800.390.52
Upgrade
Net Debt / FCF Ratio
-0.312.071.910.320.41
Upgrade
Asset Turnover
-0.030.040.060.100.09
Upgrade
Inventory Turnover
-1.592.3027.669.100.26
Upgrade
Quick Ratio
-2.6218.0121.037.133.42
Upgrade
Current Ratio
-3.2118.9922.618.016.45
Upgrade
Return on Equity (ROE)
--84.60%-32.56%-50.17%-119.51%-57.41%
Upgrade
Return on Assets (ROA)
--50.94%-24.91%-33.21%-66.72%-33.54%
Upgrade
Return on Invested Capital (ROIC)
-1188.91%-423.40%-149.73%-133.77%-218.87%-82.85%
Upgrade
Return on Capital Employed (ROCE)
--153.30%-49.50%-35.00%-126.60%-74.00%
Upgrade
Earnings Yield
-7.66%-6.50%-4.83%-11.19%-9.05%-8.05%
Upgrade
FCF Yield
--7.74%-5.31%-11.25%-10.93%-11.42%
Upgrade
Dividend Yield
----1.17%-
Upgrade
Buyback Yield / Dilution
-2.12%--22.31%-32.29%-5.88%-
Upgrade
Total Shareholder Return
-2.12%--22.31%-32.29%-4.71%-
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.